Home
0086-571-8627 3270
service@chemball.com
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >
Clindamycin Hydrochloride
CAS NO.: 21462-39-5
FOB Price: NEGOTIABLE Get Latest Price
Specification: CP2010, USP32, BP, EP, CEP
Documentation: Get COA after inquiry
Lead Time: 14-30 days
Max Capacity: -
Packing: 25KG/Fibre Drum
Product Detail
Properties

Clindamycin Hydrochloride


Basic information of clindamycin hydrochloride

CAS No.:[21462-39-5]

Chemical Name:Methyl 7-chloro-6,7,8-trideoxy-6- (1-methyl-trans-4-propyl-L-2- pyrrolidinecarboxamido)-1- thio-L-threo-a-D-galacto- octopyranoside monohydrochloride

Molecular Formula:C18H33ClN2O5S

Molecular Weight:461.44

Structural Formula:

Property:white crystalline powder,odorless. Very soluble in water, soluble in methanol or pyridine, slightly soluble in ethanol, almost insoluble in acetone or chloroform

Usage of clindamycin hydrochloride

Usage:antibiotic and anti-infective material, derivant of Lincomycin. Its mechanism is through the body of DNA with the bacteria nucleoprotein 50s subunits combination, Interfere the extension of peptide chains, effects bacteria protein synthesis for the sake of sterilization, bacteriostasis.

Package and storage of clindamycin hydrochloride

Package:25KG/Drum

Storage:sealed and preserved in tight container

Standard of clindamycin hydrochloride

Executive Standard: CP2010, USP32, BP, EP, CEP No.: R0-CEP 2010-281-REV 00


Send your message to this supplier
To:
Zhejiang Tiantai Pharmaceutical Co.,Ltd.
From:
Please enter your email
Message:
You did not fill in the message!
You can upload 6 files at most
Add Attachment
SEND SUCCESSFUL!
SEND FAILED
Not exactly what you want? One request, multiple quotations Get Quotations Now >>
26YRS
Business Type:
Manufacturing
Country/Region:
Zhejiang, China
Contacts:
Manager Guo
Position Title:
Sales Manager
Tel:
0086-576-83993758
Visit Factory
Get Free Samples
Less than 1KG required
Please enter the correct email address
Please enter quantity
Please enter remark